Filing metadata

Accession number
0001415889-24-016005
Form type
Form 4
Filer
Stoke Therapeutics, Inc.
CIK
CIK 1623526
Filed
Jun 07, 2024
Reporting period
Mar 27, 2024
Description
Insider transaction

Explore SEC Filings Hub